Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma, Squamous Cell

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

409 public trials 83 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Recruiting

Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC

NCT04564989

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
Locations: Mayo Clinic Rochester, Minnesota, United States

University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

Trident Medical Center (HCA Healthcare ) North Charleston, South Carolina, United States

View Trial Details

Recruiting

5-Fluorouracil Response and Optimization STudy (The FROST Trial)

NCT07419464

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +11 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recruiting

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

NCT07209189

Conditions: Carcinoma, Carcinoma, Squamous Cell, Communicable Diseases, +39 more
Locations: Johns Hopkins Hospital East Baltimore Baltimore, Maryland, United States

View Trial Details

Recruiting

Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin

NCT06731933

Conditions: Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +4 more
Locations: Stanford University Redwood City, California, United States

Azienda Ospedliero-Universitaia Bari, Italy

View Trial Details

Recruiting

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

NCT06561685

Conditions: Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +21 more
Locations: UCLA Santa Monica, California, United States

University of Colorado Health Hospital Aurora, Colorado, United States

Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States

Florida Cancer Specialists ORLANDO/DDU Lake Mary, Florida, United States

View all 33 locations

View Trial Details

Recruiting

Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

NCT02128906

Conditions: Carcinoma, Carcinoma, Squamous Cell, Laryngeal Diseases, +7 more
Locations: UPMC Hillman Cancer Center - Radiation Oncology Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

NCT07223424

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Bronchial Neoplasms, +70 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment

NCT06669572

Conditions: Anorectal Cancer, Carcinoma, Carcinoma, Squamous Cell, +4 more
Locations: University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Recruiting

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

NCT06753136

Conditions: Abdominal and/or Peritoneal Localizations, Adenocarcinoma, Carcinoma, +36 more
Locations: Istituto Oncologico Veneto Padova, Italy

View Trial Details

Recruiting

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

NCT06064877

Conditions: Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +14 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

The University of Arizona Cancer Center Tucson, Arizona, United States

University of California Los Angeles Los Angeles, California, United States

Yale School of Medicine - Smilow Cancer Hospital New Haven, Connecticut, United States

View all 112 locations

View Trial Details